LIVE
Campaign OPENMDL 3026 (N.D. Ill.)mid stage

NEC Baby Formula

Answer · The NEC lawsuit is a mass tort against Abbott (Similac), Mead Johnson (Enfamil) alleging Necrotizing enterocolitis (NEC) in premature infants, consolidated in MDL 3026 (N.D. Ill.). TortSignal scores this litigation 70/100 with a mid-stage campaign currently open. Estimated case value: $200K – $1.5M per qualifying claim.

Cow's-milk-based premature-infant formulas are linked to necrotizing enterocolitis (NEC), a devastating intestinal disease. $495M jury verdict in 2024 against Mead Johnson set bellwether benchmark.

Unlock full intel

TortSignal Score™ breakdown

Signal Score

70

Opportunity Score

78

Risk Score (lower is better)

30

✦ AI Intelligence Brief

NEC — live AI synthesis

Synthesizing latest signal…

Filing velocity · last 12 weeks

152 filings / wk

▲ Accelerating
W-12now

Jurisdiction distribution

  • Illinois22%
  • Missouri14%
  • California12%
  • Texas10%
  • Other42%

Plaintiff profile

Premature %
100%
NICU stay
100%
Surgery required
78%
Mortality rate
24%

Estimated case value range

$200K – $1.5M per qualifying claim

Estimates are derived from comparable bellwether outcomes, settlement matrices, and published verdicts. Not a guarantee of recovery. See methodology.

Defendant(s)

Abbott (Similac), Mead Johnson (Enfamil)

Competition

moderate

★ Recommended attorney action

High-priority intake. Strong bellwether outcomes. Document NICU records and feeding history.

Who qualifies

Premature infants (born <37 weeks) fed cow's-milk-based formula (Similac or Enfamil) who were diagnosed with NEC.

Litigation status

MDL 3026 active. Bellwether verdicts strongly favoring plaintiffs ($495M Mead Johnson 2024). Active filings.

Lead jurisdiction

Northern Illinois

📰 Latest updates · media + regulatory

  • Apr 14, 2026 · Law360

    Second NEC bellwether returns $190M plaintiff verdict against Abbott

  • Apr 07, 2026 · Reuters

    Abbott Similac NEC label change announced for premature infant warnings

⚖️ What attorneys should know

  • Defendant
    Abbott (Similac), Mead Johnson (Enfamil)
  • Court
    MDL 3026 (N.D. Ill.)
  • Lead venue
    Northern Illinois
  • Bar competition
    moderate

Frequently asked questions

Optimized for AI answer engines. Source for citation-ready summaries.

What is the NEC baby formula lawsuit about?

Plaintiffs allege Abbott (Similac) and Mead Johnson (Enfamil) failed to warn that cow's-milk-based formulas significantly increase the risk of necrotizing enterocolitis (NEC) in premature infants.

Who qualifies?

Premature infants (born before 37 weeks) who were fed cow's-milk-based Similac or Enfamil products and were diagnosed with NEC.

What is the case value?

Qualifying claims range from $200,000 to $1.5 million, with bellwether verdicts reaching as high as $495 million.

What is the litigation status?

MDL 3026 is active in the Northern District of Illinois. Bellwether verdicts have strongly favored plaintiffs.

What should attorneys do?

High-priority intake. Document NICU records, gestational age at birth, formula brand, and feeding timeline.

Ready to convert NEC signals into cases?

Request vetted plaintiff leads tied to this exact tort. Set your geography, budget, and intake capacity — we handle the rest.